UK drug discovery firm Summit, which is focused on therapies for Duchenne muscular dystrophy and Clostridium…
If there is one pharma company bucking the trend of shaky financial results it is the Clinigen Group.
BoardroomClinigen GroupFoscavirInterviewsOncologyPharmaceuticalRare diseasesUK
Our latest news direct to your inbox
Back to top